Advertisement

The Latest

From Centene signing an agreement to sell an artificial intelligence platform, to UnitedHealth Group's Optum pitching a $3.3 billion merger with a home-health provider, here are 10 payer merger and acquisition updates Becker's reported since March 31:  

Individuals who are prescribed GLP-1 or SGLT-2 drugs for diabetes and who have a low copay are more likely to take those drugs for more than one year compared to those with high copays, according to a study published June…

Advertisement